| 1. |
|
|
| 2. |
- Sumaila, U. Rashid, et al.
(författare)
-
WTO must ban harmful fisheries subsidies
- 2021
-
Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 374:6567, s. 544-544
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 3. |
- Axfors, Cathrine, et al.
(författare)
-
Association between convalescent plasma treatment and mortality in COVID-19 : a collaborative systematic review and meta-analysis of randomized clinical trials
- 2021
-
Ingår i: BMC Infectious Diseases. - : BioMed Central (BMC). - 1471-2334. ; 21:1
-
Forskningsöversikt (refereegranskat)abstract
- Background: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, ). Methods: In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung-Knapp-Sidik-Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results: A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I-2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions: Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care.
|
|
| 4. |
- Beceiro-Novo, S., et al.
(författare)
-
Coulomb dissociation of 27 P: A reaction of astrophysical interest
- 2010
-
Ingår i: Proceedings of Science. - Trieste, Italy : Sissa Medialab. - 1824-8039. ; 100
-
Konferensbidrag (refereegranskat)abstract
- The ground-state decay of 26Al(0+) (T 1/2=1.05× 106) has a shorter life-time than the Universe. The presence of this element in the Galaxy was measured via g-ray spectroscopy, showing that the nucleosynthesis of this element is an ongoing process in stars. The proton-capture reaction 26Si(p,γ) 27P competes with the production of 26Al(0+) by β-decay. Coulomb dissociation of 27P has been suggested as an indirect method to measure radiative-proton capture when the direct reaction is not feasible. Such an experiment was performed at GSI with a secondary 27P beam produced by fragmenting a 36Ar primary beam at 500 A MeV. Two main observables are preliminarily presented in this work: the reaction cross section and the relative-energy spectrum of the outgoing fragments © Copyright owned by the author(s).
|
|
| 5. |
- Marganiec, J., et al.
(författare)
-
Coulomb Dissociation experiment of 27P
- 2015
-
Ingår i: Acta Physica Polonica, Series B.. - 1509-5770 .- 0587-4254. ; 46:3, s. 473-476
-
Tidskriftsartikel (refereegranskat)abstract
- The 26Si(p; γ)27P reaction, which might play an important role in the rp process, was studied by the Coulomb Dissociation method. The experiment was performed at GSI, Darmstadt. A secondary 27P ion beam of 500 MeV/nucleon was directed onto a Pb target. From this experiment, the Coulomb Dissociation cross section, σCoulex, will be deduced and then converted to the photoabsorption cross section, σphoto, and the radiativecapture cross section, σcap. Also information on the structure of 27P will be obtained. The analysis is in progress.
|
|
| 6. |
- Marganiec, J., et al.
(författare)
-
Coulomb dissociation of P-27 at 500 MeV/u
- 2016
-
Ingår i: Physical Review C - Nuclear Physics. - 2469-9985 .- 2469-9993. ; 93:4
-
Tidskriftsartikel (refereegranskat)abstract
- The proton-capture reaction Si-26(p,gamma)(27) P was studied via Coulomb dissociation (CD) of P-27 at an incident energy of about 500 MeV/u. The three lowest-lying resonances in P-27 have been populated and their resonance strengths have been measured. In addition, a nonresonant direct-capture component was clearly identified and its astrophysical S factor measured. The experimental results are compared to Monte Carlo simulations of the CD process using a semiclassical model. Our thermonuclear reaction rates show good agreement with the rates from a recent compilation. With respect to the nuclear structure of P-27 we have found evidence for a negative-parity intruder state at 2.88-MeV excitation energy.
|
|
| 7. |
- Novo, S. B., et al.
(författare)
-
Coulomb Dissociation of 27P
- 2012
-
Ingår i: Journal of Physics: Conference Series. - : IOP Publishing. - 1742-6588 .- 1742-6596. ; 381:1
-
Konferensbidrag (refereegranskat)abstract
- In this work the astrophysical 26Si(p,γ) 27P reaction is studied using the Coulomb dissociation technique. We performed a 27P Coulomb Dissociation experiment at GSI, Darmstadt (28 May-5 June 2007) using the ALADIN-LAND setup which allows complete-kinematic studies. A secondary 27P beam at 498 AMeV impinging a 515mg/cm 2 Pb target was used. The relative energy of the outgoing system ( 26Si+p) is measured obtaining the resonant states of the 27P. Preliminary results show four resonant states measured at 0.36±0.07, 0.88±0.09, 1.5±0.2, 2.3±0.3 MeV and evidence of a higher state at around 3.1 MeV. The preliminary total cross section obtained for relative energies between 0 and 3 MeV has been measured and yields 55±7 mb.
|
|
| 8. |
- Bjurstrom, M. F., et al.
(författare)
-
Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations : A Comprehensive Review
- 2016
-
Ingår i: Pain Pract. ; 16:2, s. 183-203
-
Tidskriftsartikel (refereegranskat)abstract
- Chronic pain is a prevalent and debilitating condition, conveying immense human burden. Suffering is caused not only by painful symptoms, but also through psychopathological and detrimental physical consequences, generating enormous societal costs. The current treatment armamentarium often fails to achieve satisfying pain relief; thus, research directed toward elucidating the complex pathophysiological mechanisms underlying chronic pain syndromes is imperative. Central neuroimmune activation and neuroinflammation have emerged as driving forces in the transition from acute to chronic pain, leading to central sensitization and decreased opioid efficacy, through processes in which glia have been highlighted as key contributors. Under normal conditions, glia exert a protective role, but in different pathological states, a deleterious role is evident--directly and indirectly modulating and enhancing pain transmission properties of neurons, and shaping synaptic plasticity in a dysfunctional manner. Cytokines and neurotrophic factors have been identified as pivotal mediators involved in neuroimmune activation pathways and cascades in various preclinical chronic pain models. Research confirming these findings in humans has so far been scarce, but this comprehensive review provides coherent data supporting the clear association of a mechanistic role of altered central cytokines and neurotrophic factors in a number of chronic pain states despite varying etiologies. Given the importance of these factors in neuropathic and inflammatory chronic pain states, prospective therapeutic strategies, and directions for future research in this emerging field, are outlined.
|
|
| 9. |
|
|
| 10. |
- Giron, S. E., et al.
(författare)
-
Increased Central Nervous System Interleukin-8 in a Majority Postlaminectomy Syndrome Chronic Pain Population
- 2018
-
Ingår i: Pain Med. ; 19:5, s. 1033-1043
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND AND OBJECTIVES: Multiple processes have been identified as potential contributors to chronic pain, with increasing evidence illustrating an association with aberrant levels of neuroimmune mediators. The primary objectives of the present study were to examine central nervous system cytokines, chemokines, and growth factors present in a chronic pain population and to explore patterns of the same mediator molecules over time. Secondary objectives explored the relationship of central and peripheral neuroimmune mediators while examining the levels of anxiety, depression, sleep quality, and perception of pain associated with the chronic pain patient experience. METHODS: Cerebrospinal fluid (CSF) from a population of majority postlaminectomy syndrome patients (N = 8) was compared with control CSF samples (N = 30) to assess for significant differences in 10 cytokines, chemokines, and growth factors. The patient population was then followed over time, analyzing CSF, plasma, and psychobehavioral measures. RESULTS: The present observational study is the first to demonstrate increased mean CSF levels of interleukin-8 (IL-8; P < 0.001) in a small population of majority postlaminectomy syndrome patients, as compared with a control population. Over time in pain patients, CSF levels of IL-8 increased significantly (P < 0.001). CONCLUSIONS: These data indicate that IL-8 should be further investigated and psychobehavioral components considered in the overall chronic pain paradigm. Future studies examining the interactions between these factors and IL-8 may identify novel targets for treatment of persistent pain states.
|
|
